Cargando…
The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
BACKGROUND: Platinum-based neoadjuvant chemotherapy (NAC) is new therapeutic strategy for locally advanced cervical carcinoma, but the variables used to predict NAC response are still infrequently reported. The aim of our study was to investigate the association between XRCC1 gene single nucleotide...
Autores principales: | Cheng, Xiao-Dong, Lu, Wei-Guo, Ye, Feng, Wan, Xiao-Yun, Xie, Xing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711060/ https://www.ncbi.nlm.nih.gov/pubmed/19563645 http://dx.doi.org/10.1186/1756-9966-28-91 |
Ejemplares similares
-
ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
por: Chen, Liang, et al.
Publicado: (2016) -
Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016) -
Predictive value of single nucleotide polymorphisms in XRCC1 for radiation-induced normal tissue toxicity
por: Zhao, Jing, et al.
Publicado: (2018) -
A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies
por: Zhang, Xue Qin, et al.
Publicado: (2021) -
Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis
por: Lin, Juan, et al.
Publicado: (2018)